ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 53 filers reported holding ADC THERAPEUTICS SA in Q1 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $22,288,000 | -27.3% | 1,517,212 | 0.0% | 4.35% | +37.3% |
| Q4 2021 | $30,648,000 | -25.6% | 1,517,212 | 0.0% | 3.17% | -37.2% |
| Q3 2021 | $41,207,000 | +11.5% | 1,517,212 | 0.0% | 5.05% | +37.6% |
| Q2 2021 | $36,944,000 | -0.2% | 1,517,212 | 0.0% | 3.67% | +34.9% |
| Q1 2021 | $37,035,000 | -23.7% | 1,517,212 | 0.0% | 2.72% | +2.8% |
| Q4 2020 | $48,566,000 | -3.0% | 1,517,212 | 0.0% | 2.65% | -28.3% |
| Q3 2020 | $50,053,000 | -16.3% | 1,517,212 | +18.8% | 3.69% | -33.7% |
| Q2 2020 | $59,786,000 | – | 1,277,212 | – | 5.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,680,149 | $33,939,000 | 9.12% |
| Redmile Group, LLC | 7,451,029 | $150,511,000 | 3.42% |
| Grosvenor Holdings, L.L.C. | 1,517,212 | $30,648,000 | 3.17% |
| Indie Asset Partners, LLC | 96,582 | $1,951,000 | 1.42% |
| MPM BioImpact LLC | 337,396 | $6,815,000 | 1.24% |
| Eventide Asset Management | 1,975,000 | $39,895,000 | 0.51% |
| HHLR ADVISORS, LTD. | 500,000 | $10,100,000 | 0.16% |
| Virtus ETF Advisers LLC | 19,193 | $388,000 | 0.15% |
| CNA FINANCIAL CORP | 15,245 | $308,000 | 0.08% |
| Employees Retirement System of Texas | 278,000 | $5,616,000 | 0.06% |